bepridil has been researched along with Colitis in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsubota, M | 1 |
| Matsui, K | 1 |
| Fukushi, S | 1 |
| Okazaki, K | 1 |
| Sekiguchi, F | 1 |
| Kawabata, A | 1 |
1 other study available for bepridil and Colitis
| Article | Year |
|---|---|
Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca
Topics: Analgesics; Animals; Bepridil; Calcium Channel Blockers; Calcium Channels, T-Type; Colitis; Cyclopho | 2021 |